mesoestetic showcase at IMCAS World Congress

mesoestetic Pharma Group launched new products at this year's IMCAS World Congress in Paris, considered one of the world's most important medical aesthetic events.

The congress attracted over 10,000 delegates over three days, comprising dermatologists, aesthetic medicine professionals and plastic surgeons.

mesoesthetic showcased new solutions in hyperpigmentation with Tranexamic acid, which combines a specific peel with Mesotherapy.

Also new, the brand's home treatment, ha densimatrix, was launched. This treatment features a concentrate based on Hyaluronic acid with different molecular forms that provides the skin with a moisturising, anti-ageing, re-pulping and filling action.

As well as exhibiting products, mesoesthetic also presented their latest research findings. Dr Sabine Zenker from Germany, an expert in microinvasive and non-invasive rejuvenating treatments, presented a “Review of current evidence of antioxidants and skin aging”. Dr Zenker talked about the role of antioxidant active ingredients through solutions and treatments. She focused on the concentrate aox ferulic, the transcutaneous solution c.prof 210, and the depigmenting peel mesopeel melanoplus by mesoestetic Pharma Group.

In addition, Dr Adrián Gaspar, an Argentinian expert in gynaeco-aesthetics, shared the results of his studies on the use of carboxytherapy, Mesotherapy and fillers in the treatment of the ageing and functional regeneration processes of the genital area. Dr Gaspar discussed studies into mesoesthetic's products mesofiller and mesohyal.